Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Koen Van Besien

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Van Besien, Koen

Item TypeName
Concept Hematologic Neoplasms
Academic Article Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
Academic Article Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
Academic Article Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.
Academic Article Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?
Academic Article Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
Academic Article Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Academic Article Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
Academic Article Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
Academic Article Chimerism does not predict for outcome after alemtuzumab based conditioning.
Academic Article Successful allogeneic transplantation of patients with suspected prior invasive mold infection.
Academic Article Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
Academic Article Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
Academic Article Allogeneic stem cell transplant in renal failure: engraftment and prolonged survival, but high incidence of neurologic toxicity.
Academic Article Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.
Academic Article National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.
Academic Article Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Academic Article NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Academic Article Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
Academic Article Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?
Academic Article Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Academic Article Cord blood transplant: the glass is half full--can we do better?
Academic Article Advances in umbilical cord blood transplant: a summary of the 11th International Cord Blood Symposium, San Francisco, 6-8 June 2013.
Academic Article Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.
Academic Article The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
Academic Article Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.
Academic Article Alemtuzumab in allogeneic hematopoetic stem cell transplantation.
Academic Article Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
Academic Article Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant.
Academic Article Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
Academic Article Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy.
Academic Article The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.
Academic Article Haploidentical cord transplantation-The best of both worlds.
Academic Article Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.
Academic Article Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.
Academic Article Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies.
Academic Article Hematology and oncology clinical care during the coronavirus disease 2019 pandemic.
Academic Article MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.

Search Criteria
  • Hematopoietic Malignancies